Monoamine oxidase inhibitors: Because Dopamine is metabolized by monoamine oxidase (MAO), the effects of the drug are prolonged and intensified by MAO inhibitors. Patients who have been receiving MAO inhibitors within the previous 2-3 weeks should receive initial doses of Dopamine of no greater than 10% of the usual dose.
α-Adrenergic blocking agents: The peripheral vasoconstriction caused by high doses of Dopamine is antagonized by α-adrenergic blocking agents.
General anesthetics: Ventricular arrhythmias may occur when usual doses of Dopamine are administered during halothane (orother halogenated hydrocarbon) or cyclopropane anesthesia.
Phenytoin: Administration of IV phenytoin to patients receiving Dopamine has resulted in hypotension and bradycardia.
Other drugs: The pressor response of Dopamine may be potentiated by tricyclic antidepressants. The concomitant use of Dopamine with other vasopressors or vasoconstrictors (e.g., ergonovine) may result in severe hypertension.
Other Services
Country
Account